The Hospital-at-Home Market was valued at $5.80 Billion in 2025 and is projected to reach $23.46 Billion by 2035, growing at a CAGR of 15.0 percent over the 2026 to 2035 forecast period, according to Strategic Revenue Insights. Growth is driven mainly by hospital capacity pressure, which pushes health systems to treat acute patients in their own homes, supported by reimbursement waivers and rapidly improving remote monitoring technology.
Click here for free sample PDF: https://www.strategicrevenueinsights.com/industry/hospital-at-home-market
Hospital-at-Home Market Key Takeaways
- Market size and growth: The Hospital-at-Home Market stood at $5.80 Billion in 2025 and is forecast to reach $23.46 Billion by 2035 at a CAGR of 15.0 percent, passing $11.67 Billion by 2030.
- Largest segment: Services lead the component segment with a 48 percent share, worth $2.78 Billion in 2025, while skilled nursing is the largest service line with a 38 percent share.
- Leading end user: Providers account for 61 percent of spending, about $3.54 Billion in 2025, while payers are the fastest-growing end user at a 16.2 percent CAGR.
- Leading region: North America holds a 52.07 percent share worth $3.02 Billion in 2025, while Asia Pacific is the fastest-growing region at an 18.1 percent CAGR.
- Top key players: Medically Home, DispatchHealth, Biofourmis, Philips Healthcare and Masimo lead the market, and the five largest companies hold about 35 percent of global revenue.
Hospital-at-Home Market at a Glance
| Report Attribute | Details |
|---|---|
| Market size in 2025 | $5.80 Billion |
| Projected market size in 2035 | $23.46 Billion |
| CAGR (2026 to 2035) | 15.0 percent |
| Historic period | 2018 to 2024 |
| Largest segment | Services (48 percent share of component segment) |
| Fastest-growing segment | Telehealth Monitoring (18.1 percent CAGR) |
| Largest region | North America (52.07 percent share) |
| Fastest-growing region | Asia Pacific (18.1 percent CAGR) |
| Segments covered | Service, Component, Condition, End User, Region |
| Report source | Strategic Revenue Insights (Report ID 91778, 200 pages) |
What Is Driving Hospital-at-Home Market Growth
Hospital capacity pressure is the strongest driver of the Hospital-at-Home Market, adding an estimated 5.5 percentage points to the growth rate in the short term. Hospitals in North America and Europe face full wards, long emergency department waits and rising costs per bed, so moving stable acute patients into supervised home care frees capacity without new construction. Reimbursement waivers and payer support add another 4.5 points, as public and private payers in the United States have extended payment rules that treat qualifying home care episodes like inpatient stays.
Remote monitoring technology contributes a further 4.0 points over the medium term. Wearable sensors, connected infusion pumps and software platforms now stream vital signs to clinical command centres, which lets one nursing team watch many patients at once and intervene early. Ageing populations and the rising burden of chronic respiratory disease and heart failure add 3.0 points over the long term, because these conditions produce frequent, predictable admissions that suit home-based protocols. Together these drivers contribute about 17.0 points, against 4.0 points lost to reimbursement uncertainty and operational complexity.
Segment Insights: Services, Skilled Nursing and Providers
By component, services lead with a 48 percent share, or $2.78 Billion in 2025, rising to $9.17 Billion by 2035 at a 12.7 percent CAGR. Remote monitoring devices hold 29 percent, about $1.68 Billion, and are forecast to reach $7.58 Billion at a 16.2 percent CAGR, while software platforms are the fastest-growing component at 17.5 percent, climbing from $1.33 Billion to $6.71 Billion. By service, skilled nursing is the largest line with a 38 percent share worth $2.20 Billion, followed by infusion therapy at 27 percent and telehealth monitoring at 23 percent, which is the fastest-growing service at an 18.1 percent CAGR. Rehabilitation accounts for the remaining 12 percent.
By condition, chronic respiratory disease leads with a 24 percent share, about $1.39 Billion in 2025, followed by heart failure at 22 percent, infections at 20 percent and post-surgical care at 16 percent, which is the fastest-growing condition at a 16.3 percent CAGR. By end user, providers dominate with a 61 percent share worth $3.54 Billion, growing to $13.46 Billion by 2035, while payers hold 26 percent and grow fastest at 16.2 percent as insurers fund programs that cut readmissions. Patients paying directly make up the remaining 13 percent of the market.
Regional Dynamics Shaping the Hospital-at-Home Market
North America is the largest regional market with a 52.07 percent share worth $3.02 Billion in 2025, and it is expected to reach $10.75 Billion by 2035 at a 13.5 percent CAGR. The region benefits from established acute hospital care at home waivers, large health systems with command centre infrastructure and a mature remote monitoring device industry. Europe holds a 23.97 percent share, growing from $1.39 Billion to $5.66 Billion at a 15.1 percent CAGR, with national health services using home-based care to manage winter capacity and chronic disease.
Asia Pacific is the fastest-growing region, expanding at an 18.1 percent CAGR from $1.04 Billion in 2025 to $5.49 Billion by 2035, as private hospital groups in markets such as Japan, Australia, China and India adopt home-based acute care to serve ageing populations. Latin America and the Middle East and Africa each hold about 3 percent of the market, with Latin America growing from $174 Million to $770.86 Million at a 16.0 percent CAGR and the Middle East and Africa rising from $174 Million to $804.74 Million at a 16.5 percent CAGR.
Competitive Landscape
The Hospital-at-Home Market is moderately fragmented, with the five largest companies holding about 35 percent of global revenue and the top seven about 43.5 percent. Medically Home leads with an estimated 9.5 percent share, followed by DispatchHealth at 8.0 percent, Biofourmis at 6.5 percent, Philips Healthcare at 6.0 percent and Masimo at 5.0 percent. The leaders compete on the depth of their clinical protocols, the reach of their field nursing and paramedic networks, and the ability of their software to integrate with hospital electronic health records.
Current Health, with about 4.5 percent, and Medtronic, with about 4.0 percent, strengthen the device and monitoring side of the market, while GE HealthCare supplies monitoring and imaging technology. Contessa Health partners with health systems to run full home hospital programs, and Mass General Brigham operates one of the largest provider-led programs and shares its operating model with other systems. Partnerships between device makers, software platforms and large hospital groups are the main route to scale.
Opportunities and Challenges Ahead
Key opportunities include payer-backed programs for heart failure and chronic respiratory disease, which together account for 46 percent of condition spending, expansion into European and Asia Pacific health systems, AI-driven early deterioration alerts that improve patient safety, and post-surgical recovery pathways at home, which are growing at a 16.3 percent CAGR. Condition-specific care bundles are expected to win over general platforms as the market matures.
The main restraints are reimbursement uncertainty, which removes about 2.5 points from growth as temporary waivers come up for renewal, and operational complexity in logistics, staffing and patient eligibility, which removes a further 1.5 points. Other challenges include clinician and nursing workforce shortages, the risk of patient safety incidents in home settings, and fragmented integration between monitoring devices and hospital record systems.
Hospital-at-Home Market Outlook to 2035
The Hospital-at-Home Market is set to quadruple over the next decade, from $5.80 Billion in 2025 to $23.46 Billion by 2035 at a CAGR of 15.0 percent. Strategic Revenue Insights projects a downside of $17.50 Billion if waivers lapse and an upside of $28.50 Billion if permanent payment rules and broad payer adoption arrive. Services, skilled nursing and provider-led programs will remain the core of the market, while telehealth monitoring, software platforms and Asia Pacific supply the fastest growth. Related coverage from Strategic Revenue Insights is available in the Healthcare category on this blog.
Frequently Asked Questions About the Hospital-at-Home Market
The Hospital-at-Home Market was valued at $5.80 Billion in 2025 and is projected to reach $23.46 Billion by 2035, according to Strategic Revenue Insights.
The market is expected to grow at a CAGR of 15.0 percent from 2026 to 2035, reaching about $11.67 Billion by 2030.
Services lead the component segment with a 48 percent share in 2025, and skilled nursing is the largest service line with a 38 percent share. Telehealth monitoring is the fastest-growing service at an 18.1 percent CAGR.
Asia Pacific is the fastest-growing region at an 18.1 percent CAGR, while North America is the largest region with a 52.07 percent share.
Key players include Medically Home, DispatchHealth, Biofourmis, Philips Healthcare, Masimo, Current Health, Medtronic, GE HealthCare, Contessa Health and Mass General Brigham.
Growth is driven by hospital capacity pressure, reimbursement waivers and payer support, and remote monitoring technology, while reimbursement uncertainty and operational complexity are the main challenges.
About Strategic Revenue Insights Inc.
Strategic Revenue Insights Inc., a distinguished subsidiary of SRI Consulting Group Ltd, stands as a premier provider of data-driven market intelligence, empowering organizations globally to navigate complex business landscapes with confidence and precision. Headquartered in London, United Kingdom, our firm specializes in delivering comprehensive syndicated research reports, bespoke consulting solutions, and actionable strategic insights that enable clients to make informed, forward-thinking decisions in an increasingly competitive marketplace.
Our dedicated team of accomplished analysts, strategically positioned in London with an extensive global network, maintains continuous vigilance over evolving market dynamics, identifying emerging trends and uncovering high-potential growth opportunities that drive sustained client success. As an integral component of SRI Consulting Group Ltd, we uphold unwavering commitments to analytical accuracy, clarity of presentation, and practical applicability, assisting organizations in navigating competitive terrain, optimizing strategic initiatives, and accelerating revenue trajectories.
Through the integration of rigorous research methodologies with profound industry expertise, Strategic Revenue Insights Inc. delivers comprehensive market perspectives that generate measurable outcomes and establish enduring competitive advantages for our clients across diverse sectors and geographies.
Media Contact Information
Company Name: Strategic Revenue Insights Inc.
Contact Person: Rohit Bhisey
Email: sales@strategicrevenueinsights.com
Phone: +44 7877403352
Address: Suite 10, Capital House, 61 Amhurst Road, E8 1LL
City: London
State: London
Country: United Kingdom
Corporate Websites:
www.strategicrevenueinsights.com
www.strategicpackaginginsights.com
www.sriconsultinggroupltd.com
https://strategicrevenueinsights.blog/
https://www.medium.com/@strategic-revenue-insights.inc
For partnership inquiries, custom research requests, or detailed market analysis consultations, we invite you to connect with our team of experts who are committed to delivering strategic intelligence that transforms business outcomes.